19
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Significance of Serum Type-IV Collagen Levels in Various Liver Diseases Measurement with a One-Step Sandwich Enzyme Immunoassay Using Monoclonal Antibodies with Specificity for Pepsin-Solubilized Type-IV Collagen

, , , , , , , & show all
Pages 513-520 | Received 13 Sep 1991, Accepted 13 Jan 1992, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

H. Verbaan, L. Bondeson & S. Eriksson. (1997) Non-Invasive Assessment of Inflammatory Activity and Fibrosis (Grade and Stage) in Chronic Hepatitis C Infection. Scandinavian Journal of Gastroenterology 32:5, pages 494-499.
Read now
Jian Wu & ÅKe Danielson. (1995) Detection of Hepatic Fibrogenesis: A Review of Available Techniques. Scandinavian Journal of Gastroenterology 30:9, pages 817-825.
Read now
K. Yabu, K. Kiyosawa, H. Mori, A. Matsumoto, K. Yoshizawa, E. Tanaka & S Furuta. (1994) Serum Collagen Type IV for the Assessment of Fibrosis and Resistance to Interferon Therapy in Chronic Hepatitis C. Scandinavian Journal of Gastroenterology 29:5, pages 474-479.
Read now

Articles from other publishers (29)

Yasushi Honda, Masato Yoneda, Takashi Kobayashi, Michihiro Iwaki, Nobuyoshi Kawamura, Asako Nogami, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Nobuyuki Horita, Satoru Saito, Takeshi Kaneko & Atsushi Nakajima. (2022) Meta‐analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatology Research 53:3, pages 219-227.
Crossref
Pratima Nangia-Makker, Victor Hogan, Vitaly Balan & Avraham Raz. (2022) Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases. Journal of Biological Chemistry 298:12, pages 102622.
Crossref
Koji Fujita & Tsutomu Masaki. (2021) Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept “Compensated Advanced Chronic Liver Disease”. Journal of Clinical Medicine 10:15, pages 3340.
Crossref
Anita Saraf, Christine De Staercke, Ian Everitt, Alice Haouzi, Yi-An Ko, Staci Jennings, Jonathan H. Kim, Fred H. Rodriguez, Andreas P. Kalogeropoulos, Arshed Quyyumi & Wendy Book. (2020) Biomarker profile in stable Fontan patients. International Journal of Cardiology 305, pages 56-62.
Crossref
Ki M. Mak & Rena Mei. (2017) Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver Disease. The Anatomical Record 300:8, pages 1371-1390.
Crossref
Hind I. Fallatah. (2014) Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014, pages 1-15.
Crossref
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn & Dong Joon Kim. 2013. 33 122 .
Vincenza Calvaruso & Antonio Craxì. (2009) Implication of normal liver enzymes in liver disease. Journal of Viral Hepatitis 16:8, pages 529-536.
Crossref
Diarmuid S. Manning & Nezam H. Afdhal. (2008) Diagnosis and Quantitation of Fibrosis. Gastroenterology 134:6, pages 1670-1681.
Crossref
M. Yoneda, M. Yoneda, H. Mawatari, K. Fujita, H. Endo, H. Iida, Y. Nozaki, K. Yonemitsu, T. Higurashi, H. Takahashi, N. Kobayashi, H. Kirikoshi, Y. Abe, M. Inamori, K. Kubota, S. Saito, M. Tamano, H. Hiraishi, S. Maeyama, N. Yamaguchi, S. Togo & A. Nakajima. (2008) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Digestive and Liver Disease 40:5, pages 371-378.
Crossref
Masato Yoneda, Hironori Mawatari, Koji Fujita, Kyoko Yonemitsu, Shingo Kato, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Yasunobu Abe, Kensuke Kubota, Satoru Saito, Tomoyuki Iwasaki, Yasuo Terauchi, Shinji Togo, Shiro Maeyama & Atsushi Nakajima. (2007) Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. Journal of Gastroenterology 42:5, pages 375-381.
Crossref
Shoji Kubo, Tadashi Tsukamoto, Kazuhiro Hirohashi, Hiromu Tanaka, Taichi Shuto, Shigekazu Takemura, Takatsugu Yamamoto, Takahiro Uenishi, Masao Ogawa & Hiroaki Kinoshita. (2004) Correlation Between Preoperative Serum Concentration of Type IV Collagen 7s Domain and Hepatic Failure Following Resection of Hepatocellular Carcinoma. Annals of Surgery 239:2, pages 186-193.
Crossref
Kevin Michael Walsh, Alexander Fletcher, Roderick N.M MacSween & Allan John Morris. (2000) Basement membrane peptides as markers of liver disease in chronic hepatitis C. Journal of Hepatology 32:2, pages 325-330.
Crossref
Shoji Kubo, Takatsugu Yamamoto, Takashi Ikebe, Taichi Shuto, Kazuhiro Hirohashi, Hiromu Tanaka, Tadashi Tsukamoto, Kenichi Wakasa & Hiroaki Kinoshita. (1999) Relationship between Multicentric Occurrence of Hepatocellular Carcinoma and Histology of Noncancerous Hepatic Tissue in Patients with Chronic Hepatitis C. Japanese Journal of Cancer Research 90:10, pages 1076-1080.
Crossref
D.Keith George, Grant A Ramm, Neal I Walker, Lawrie W Powell & Darrell H.G Crawford. (1999) Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis. Journal of Hepatology 31:1, pages 47-52.
Crossref
Lu Liu. (1999) Clinical and experimental study on regional administration of phosphorus 32 glass microspheres in treating hepatic carcinoma. World Journal of Gastroenterology 5:6, pages 492.
Crossref
C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, Y. FUKUDA, I. NAKANO, Y. KATANO, H. TOYODA, M. IMOTO, J. TAKAMATSU, H. SAITO & T. HAYAKAWA. (2003) Assessment and treatment of liver disease in Japanese haemophilia patients. Haemophilia 4:4, pages 595-600.
Crossref
Hiroyuki Kobayashi, Takeshi Miyano, Kentaro Horikoshi & Akifumi Tokita. (1998) Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia. Journal of Pediatric Surgery 33:1, pages 112-114.
Crossref
Mieko Ebata, Yoshihide Fukuda, Isao Nakano, Yoshiaki Katano, Noboru Fujimoto & Tetsuo Hayakawa. (2008) Serum levels of tissue inhibitor of metalloproteinases-2 and of precursor form of matrix metalloproteinase-2 in patients with liver disease. Liver 17:6, pages 293-299.
Crossref
Seigo Takamatsu, Hitomi Nakabayashi, Yasuyuki Okamoto & Hiroshi Nakano. (1997) Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables. Journal of Gastroenterology 32:3, pages 355-360.
Crossref
Carlo Fabris, Edmondo Falleti, Edda Federico, Pierluigi Toniutto & Mario Pirisi. (2016) A Comparison of Four Serum Markers of Fibrosis in the Diagnosis of Cirrhosis. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 34:2, pages 151-155.
Crossref
Chisato Hirayama, Hiroshi Suzuki, Akira Takada, Kiyoshi Fujisawa, Kyuichi Tanikawa & Shogo Igarashi. (1996) Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide. Journal of Gastroenterology 31:2, pages 242-248.
Crossref
Takato Ueno, Seishu Tamaki, Hiroshi Sugawara, Sadataka Inuzuka, Takuji Torimura, Michio Sata & Kyuichi Tanikawa. (1996) Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. Journal of Hepatology 24:2, pages 177-184.
Crossref
Yoshikazu Murawaki, Yujiro Ikuta, Masahiko Koda, Sadako Yamada & Hironaka Kawasaki. (1996) Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. Journal of Hepatology 24:2, pages 148-154.
Crossref
Yoshikazu Murawaki, Yujiro Ikuta, Yuuko Nishimura, Masahiko Koda & Hironaka Kawasaki. (1995) Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: A comparative analysis. Journal of Hepatology 23:2, pages 145-152.
Crossref
Carlo Fabris, Mario Pirisi, Edmondo Falleti, Giorgio Soardo, Fabio Gonano & Ettore Bartoli. (1994) Prediction of serum markers of fibrosis by levels of circulating intercellular adhesion molecule-1 in acute and chronic liver disease. Clinical Biochemistry 27:5, pages 407-412.
Crossref
Yoshikazu Murawaki, Yujiro Ikuta, Masahiko Koda & Hironaka Kawasaki. (1994) Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology. Hepatology 20:4, pages 780-787.
Crossref
Giorgio Tamaro, Michele Moretti, Paola Marchi, Mariangela Mangiarotti & Gabriele Pozzato. (1994) Serum type IV collagen and prolyl hydroxylase levels: effect of gender and age. Clinica Chimica Acta 228:2, pages 205-210.
Crossref
Takato Ueno, Sadataka Inuzuka & Kyuichi Tanikawa. (1993) Changes of the extracellular matrix and cells producing it in acute liver injury. Gastroenterologia Japonica 28:S4, pages 107-111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.